Welcome to mSMART: the risk adapted approach to management of multiple myeloma and related disorders

Ansell, Stephen, M.D., Ph.D.
Our MISSION is to present the state of the art approach to management of these plasma cells disorders including myeloma, amyloidosis, and Waldenstroms Macroglobulinemia. Views expressed here are opinions of a group of experts, based on best available evidence
Use the links on the left to navigate to specific pages
Lacy, Martha Q. M.D.

Stratification for Myeloma And Risk-adapted Therapy

Bergsagel, Leif M.D.
Buadi, Francis K. M.D.
Dalton, Robert J. M.D.
Detweiler-Short, Kristen, N.P
Dingli, David M.D., Ph.D.
Dispenzieri, Angela M.D.
Fonseca, Rafael M.D.
Gertz, Morie A. M.D.
Greipp, Philip R. M.D.
Hayman, Suzanne R. M.D.
Kumar, Shaji M.D.
Lust, John A. M.D., Ph.D.
Mikhael, Joseph, M.D.
Nowakowski, Greg, M.D.
Rajkumar, S. Vincent. M.D.
Reeder, Craig B. M.D.
Roy, Vivek M. M.D.
Russell, Stephen J. M.D., Ph.D.
Stewart, Keith M.B.,Ch.B.
Witzig, Thomas E. M.D.
Zeldenrust, Steven R. M.D., Ph.D
Kyle, Robert A. M.D.